Tracking migraine relief: does this pill work the same every time?
NCT ID NCT06898047
Summary
This study aims to understand how consistently a migraine medication called rimegepant works for people in real life. It will follow 250 adults in the UK who already have a prescription for this drug to treat their migraine attacks. Participants will report their symptoms and medication use daily for 12 weeks to see how reliably the drug provides pain relief and improves other symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer
London, United Kingdom
Conditions
Explore the condition pages connected to this study.